Living with Hemophilia B?

Living with Hemophilia B?

Doctors are studying an investigational therapy named SB-FIX which is based on in vivo genome editing, a type of targeted gene therapy. SB-FIX was designed with the goal of providing a lasting treatment for adults with severe hemophilia B.

The FIXtendz study will test SB-FIX to see if it’s safe and tolerable, and determine whether or not it is effective at enabling your body to produce Factor IX (FIX) protein on its own to improve blood clotting. Please have a look around the site for more information about this study and in vivo genome editing.